| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.004 | 10.184 | 8.675 | 11.968 | 6.016 | 8.721 | 14.524 | 9.268 | 9.193 |
| Total Income - EUR | - | 4.004 | 10.162 | 8.676 | 12.012 | 6.016 | 8.721 | 14.524 | 9.268 | 9.209 |
| Total Expenses - EUR | - | 4.309 | 8.111 | 6.018 | 8.307 | 4.772 | 5.722 | 9.118 | 12.411 | 16.675 |
| Gross Profit/Loss - EUR | - | -305 | 2.052 | 2.658 | 3.705 | 1.245 | 2.999 | 5.406 | -3.143 | -7.466 |
| Net Profit/Loss - EUR | - | -425 | 1.746 | 2.398 | 3.345 | 1.079 | 2.737 | 4.979 | -3.280 | -7.466 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biochem Reagents Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 306 | 301 | 296 | 290 | 0 | 0 | 0 | 58.214 | 47.363 |
| Current Assets | - | 3.758 | 2.012 | 3.503 | 3.513 | 1.777 | 4.520 | 7.206 | 3.487 | 3.727 |
| Inventories | - | 91 | 0 | 7 | 0 | 0 | 16 | 23 | 130 | 25 |
| Receivables | - | 776 | 189 | 1.129 | 34 | 33 | 553 | 1.640 | 398 | 204 |
| Cash | - | 2.891 | 1.822 | 2.367 | 3.479 | 1.744 | 3.950 | 5.543 | 2.958 | 3.498 |
| Shareholders Funds | - | -381 | 1.372 | 2.449 | 3.513 | 1.321 | 2.973 | 5.203 | -2.540 | -9.992 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.445 | 941 | 1.349 | 290 | 456 | 1.546 | 2.003 | 64.365 | 61.210 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4669 - 4669" | |||||||||
| CAEN Financial Year |
4669
|
|||||||||
Comments - Biochem Reagents Srl